Acute hepatitis due to olmesartan: an uncommon entity.

Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva
Cristina Rubín de CélixLuisa García-Buey

Abstract

We report the case of a hypertensive 54-year-old female who had been under treatment with olmesartan (40 mg daily) for a month. She was referred due to hypertransaminasemia and also reported asthenia and a 7 kg weight loss.

References

Aug 13, 2002·European Journal of Gastroenterology & Hepatology·Raúl J AndradeFrancisco Pulido-Fernandez
Apr 25, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sandrine BargeJean-Charles Nault
Mar 31, 2019·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.euUNKNOWN EASL Governing Board representative:
Aug 20, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Shannon KogachiVinay Sundaram
Feb 15, 2020·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Alicia Martín-Lagos MaldonadoMyriam Del Carmen Herrera Mercader

❮ Previous
Next ❯

Citations

Sep 18, 2021·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Joseph William ClintonJames H Lewis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
Hans R Brunner, P Laeis
© 2021 Meta ULC. All rights reserved